Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -6.58% vs -2.11% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 6.12% vs -25.31% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -19.82% vs -27.77% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 51.61% vs -46.55% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of GuiZhou SanLi Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 13.37% vs 14.84% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -6.58% vs -2.11% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 2,752.94% vs -103.96% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 6.12% vs -25.31% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 5,440.00% vs -101.69% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -19.82% vs -27.77% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 840.00% vs -85.71% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 51.61% vs -46.55% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Sep 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






